-
1
-
-
0033918563
-
Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3
-
Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 2000;25:315-9.
-
(2000)
Nat Genet
, vol.25
, pp. 315-319
-
-
Dammann, R.1
Li, C.2
Yoon, J.H.3
Chin, P.L.4
Bates, S.5
Pfeifer, G.P.6
-
2
-
-
0031004936
-
Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes
-
Kok K, Naylor SL, Buys CH. Deletions of the short arm of chromosome 3 in solid tumors and the search for suppressor genes. Adv Cancer Res 1997;71:27-92.
-
(1997)
Adv Cancer Res
, vol.71
, pp. 27-92
-
-
Kok, K.1
Naylor, S.L.2
Buys, C.H.3
-
3
-
-
7344247650
-
Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene
-
Sekido Y, Ahmadian M, Wistuba II, et al. Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene. Oncogene 1998;16:3151-7.
-
(1998)
Oncogene
, vol.16
, pp. 3151-3157
-
-
Sekido, Y.1
Ahmadian, M.2
Wistuba, I.I.3
-
4
-
-
0034327412
-
The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: Identification and evaluation of the resident candidate tumor suppressor genes
-
The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium
-
Lerman MI, Minna JD. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Res 2000;60:6116-33.
-
(2000)
Cancer Res
, vol.60
, pp. 6116-6133
-
-
Lerman, M.I.1
Minna, J.D.2
-
5
-
-
0035795676
-
Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression
-
Burbee DG, Forgacs E, Zochbauer-Muller S, et al. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst 2001;93:691-9.
-
(2001)
J Natl Cancer Inst
, vol.93
, pp. 691-699
-
-
Burbee, D.G.1
Forgacs, E.2
Zochbauer-Muller, S.3
-
7
-
-
0035932393
-
Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours
-
Agathanggelou A, Honorio S, Macartney DP, et al. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. Oncogene 2001;20:1509-18.
-
(2001)
Oncogene
, vol.20
, pp. 1509-1518
-
-
Agathanggelou, A.1
Honorio, S.2
Macartney, D.P.3
-
8
-
-
0036339479
-
Methylation of the RASSF1A gene in human cancers
-
Pfeifer GP, Yoon JH, Liu L, Tommasi S, Wilczynski SP, Dammann R. Methylation of the RASSF1A gene in human cancers. Biol Chem 2002;383:907-14.
-
(2002)
Biol Chem
, vol.383
, pp. 907-914
-
-
Pfeifer, G.P.1
Yoon, J.H.2
Liu, L.3
Tommasi, S.4
Wilczynski, S.P.5
Dammann, R.6
-
9
-
-
0037379520
-
Epigenetic inactivation of the Ras-association domain family 1 (RASSF1A) gene and its function in human carcinogenesis
-
Dammann R, Schagdarsurengin U, Strunnikova M, et al. Epigenetic inactivation of the Ras-association domain family 1 (RASSF1A) gene and its function in human carcinogenesis. Histol Histopathol 2003;18:665-77.
-
(2003)
Histol Histopathol
, vol.18
, pp. 665-677
-
-
Dammann, R.1
Schagdarsurengin, U.2
Strunnikova, M.3
-
10
-
-
0035300429
-
Hypermethylation of the CpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers
-
Dammann R, Yang G, Pfeifer GP. Hypermethylation of the CpG island of Ras association domain family 1A (RASSF1A), a putative tumor suppressor gene from the 3p21.3 locus, occurs in a large percentage of human breast cancers. Cancer Res 2001;61:3105-9.
-
(2001)
Cancer Res
, vol.61
, pp. 3105-3109
-
-
Dammann, R.1
Yang, G.2
Pfeifer, G.P.3
-
11
-
-
0035912820
-
The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis
-
Dreijerink K, Braga E, Kuzmin I, et al. The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis. Proc Natl Acad Sci U S A 2001;98:7504-9.
-
(2001)
Proc Natl Acad Sci U S A
, vol.98
, pp. 7504-7509
-
-
Dreijerink, K.1
Braga, E.2
Kuzmin, I.3
-
12
-
-
0037096818
-
The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells
-
Kuzmin I, Gillespie JW, Protopopov A, et al. The RASSF1A tumor suppressor gene is inactivated in prostate tumors and suppresses growth of prostate carcinoma cells. Cancer Res 2002;62:3498-502.
-
(2002)
Cancer Res
, vol.62
, pp. 3498-3502
-
-
Kuzmin, I.1
Gillespie, J.W.2
Protopopov, A.3
-
13
-
-
0037015688
-
Frequent hypermethylation of the BASSF1A gene in prostate cancer
-
Liu L, Yoon JH, Dammann R, Pfeifer GP. Frequent hypermethylation of the BASSF1A gene in prostate cancer. Oncogene 2002;21:6835-40.
-
(2002)
Oncogene
, vol.21
, pp. 6835-6840
-
-
Liu, L.1
Yoon, J.H.2
Dammann, R.3
Pfeifer, G.P.4
-
14
-
-
0036644895
-
Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma
-
Schagdarsurengin U, Gimm O, Hoang-Vu C, Dralle H, Pfeifer GP, Dammann R. Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma. Cancer Res 2002;62:3698-701.
-
(2002)
Cancer Res
, vol.62
, pp. 3698-3701
-
-
Schagdarsurengin, U.1
Gimm, O.2
Hoang-Vu, C.3
Dralle, H.4
Pfeifer, G.P.5
Dammann, R.6
-
15
-
-
0037468934
-
Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma
-
Schagdarsurengin U, Wilkens L, Steinemann D, et al. Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma. Oncogene 2003;22:1866-71.
-
(2003)
Oncogene
, vol.22
, pp. 1866-1871
-
-
Schagdarsurengin, U.1
Wilkens, L.2
Steinemann, D.3
-
16
-
-
0035858992
-
The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas
-
Dammann R, Takahashi T, Pfeifer GP. The CpG island of the novel tumor suppressor gene RASSF1A is intensely methylated in primary small cell lung carcinomas. Oncogene 2001;20:3563-7.
-
(2001)
Oncogene
, vol.20
, pp. 3563-3567
-
-
Dammann, R.1
Takahashi, T.2
Pfeifer, G.P.3
-
17
-
-
0035476868
-
Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma
-
Morrissey C, Martinez A, Zatyka M, et al. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma. Cancer Res 2001;61:7277-81.
-
(2001)
Cancer Res
, vol.61
, pp. 7277-7281
-
-
Morrissey, C.1
Martinez, A.2
Zatyka, M.3
-
18
-
-
0035872408
-
High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma
-
Lo KW, Kwong J, Hui AB, et al. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res 2001;61:3877-81.
-
(2001)
Cancer Res
, vol.61
, pp. 3877-3881
-
-
Lo, K.W.1
Kwong, J.2
Hui, A.B.3
-
19
-
-
0035476236
-
Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma
-
Byun DS, Lee MG, Chae KS, Ryu BG, Chi SG. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma. Cancer Res 2001;61:7034-8.
-
(2001)
Cancer Res
, vol.61
, pp. 7034-7038
-
-
Byun, D.S.1
Lee, M.G.2
Chae, K.S.3
Ryu, B.G.4
Chi, S.G.5
-
20
-
-
0037461896
-
Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours
-
Honorio S, Agathanggelou A. Wernert N, Rothe M, Maher ER, Latif F. Frequent epigenetic inactivation of the RASSF1A tumour suppressor gene in testicular tumours and distinct methylation profiles of seminoma and nonseminoma testicular germ cell tumours. Oncogene 2003;22:461-6.
-
(2003)
Oncogene
, vol.22
, pp. 461-466
-
-
Honorio, S.1
Agathanggelou, A.2
Wernert, N.3
Rothe, M.4
Maher, E.R.5
Latif, F.6
-
21
-
-
0037400977
-
Frequent hypermethylation of promoter region of RASSF1A in tumor tissues and voided urine of urinary bladder cancer patients
-
Chan MW, Chan LW, Tang NL, et al. Frequent hypermethylation of promoter region of RASSF1A in tumor tissues and voided urine of urinary bladder cancer patients. Int J Cancer 2003;104:611-6.
-
(2003)
Int J Cancer
, vol.104
, pp. 611-616
-
-
Chan, M.W.1
Chan, L.W.2
Tang, N.L.3
-
22
-
-
0035884193
-
Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma
-
Lee MG, Kim HY, Byun DS, et al. Frequent epigenetic inactivation of RASSF1A in human bladder carcinoma. Cancer Res 2001;61:6688-92.
-
(2001)
Cancer Res
, vol.61
, pp. 6688-6692
-
-
Lee, M.G.1
Kim, H.Y.2
Byun, D.S.3
-
23
-
-
0037108984
-
Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development
-
Lusher ME, Lindsey JC, Latif F, Pearson AD, Ellison DW, Clifford SC. Biallelic epigenetic inactivation of the RASSF1A tumor suppressor gene in medulloblastoma development. Cancer Res 2002;62:5906-11.
-
(2002)
Cancer Res
, vol.62
, pp. 5906-5911
-
-
Lusher, M.E.1
Lindsey, J.C.2
Latif, F.3
Pearson, A.D.4
Ellison, D.W.5
Clifford, S.C.6
-
24
-
-
0035893756
-
Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features
-
Maruyama R, Toyooka S, Toyooka KO, et al. Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. Cancer Res 2001;61:8659-63.
-
(2001)
Cancer Res
, vol.61
, pp. 8659-8663
-
-
Maruyama, R.1
Toyooka, S.2
Toyooka, K.O.3
-
25
-
-
0037380925
-
Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma
-
Spugnardi M, Tommasi S, Dammann R, Pfeifer GP, Hoon DS. Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma. Cancer Res 2003;63:1639-43.
-
(2003)
Cancer Res
, vol.63
, pp. 1639-1643
-
-
Spugnardi, M.1
Tommasi, S.2
Dammann, R.3
Pfeifer, G.P.4
Hoon, D.S.5
-
26
-
-
0037142622
-
Progressive aberrant methylation of the RASSF1A gene in simian virus 40 infected human mesothelial cells
-
Toyooka S, Carbone M, Toyooka KO, et al. Progressive aberrant methylation of the RASSF1A gene in simian virus 40 infected human mesothelial cells. Oncogene 2002;21:4340-4.
-
(2002)
Oncogene
, vol.21
, pp. 4340-4344
-
-
Toyooka, S.1
Carbone, M.2
Toyooka, K.O.3
-
27
-
-
18444408077
-
K-ras mutations and RASSF1A promoter methylation in colorectal cancer
-
van Engeland M, Roemen GM, Brink M, et al. K-ras mutations and RASSF1A promoter methylation in colorectal cancer. Oncogene 2002;21:3792-5.
-
(2002)
Oncogene
, vol.21
, pp. 3792-3795
-
-
Van Engeland, M.1
Roemen, G.M.2
Brink, M.3
-
28
-
-
18644383745
-
Frequent RASSF1A tumour suppressor gene promoter methylation in Wilms' tumour and colorectal cancer
-
Wagner KJ, Cooper WN, Grundy RG, et al. Frequent RASSF1A tumour suppressor gene promoter methylation in Wilms' tumour and colorectal cancer. Oncogene 2002;21:7277-82.
-
(2002)
Oncogene
, vol.21
, pp. 7277-7282
-
-
Wagner, K.J.1
Cooper, W.N.2
Grundy, R.G.3
-
29
-
-
0036789450
-
High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma
-
Zhang YJ, Ahsan H, Chen Y, et al. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma. Mol Carcinog 2002;35:85-92.
-
(2002)
Mol Carcinog
, vol.35
, pp. 85-92
-
-
Zhang, Y.J.1
Ahsan, H.2
Chen, Y.3
-
30
-
-
0141954011
-
Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer
-
Yan PS, Shi H, Rahmatpanah F, et al. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer. Cancer Res 2003;63:6178-86.
-
(2003)
Cancer Res
, vol.63
, pp. 6178-6186
-
-
Yan, P.S.1
Shi, H.2
Rahmatpanah, F.3
-
31
-
-
0036184623
-
Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features
-
Maruyama R, Toyooka S, Toyooka KO, et al. Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features. Clin Cancer Res 2002;8:514-9.
-
(2002)
Clin Cancer Res
, vol.8
, pp. 514-519
-
-
Maruyama, R.1
Toyooka, S.2
Toyooka, K.O.3
-
32
-
-
0041695472
-
Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas
-
Zhang S, Yeo W, Tang MV, Wong N, Lai PB, Johnson PJ. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas. Clin Cancer Res 2003;9:3376-82.
-
(2003)
Clin Cancer Res
, vol.9
, pp. 3376-3382
-
-
Zhang, S.1
Yeo, W.2
Tang, M.V.3
Wong, N.4
Lai, P.B.5
Johnson, P.J.6
-
33
-
-
0032489384
-
Identification of Nore1 as a potential Ras effector
-
Vavvas D, Li X, Avruch J, Zhang XF. Identification of Nore1 as a potential Ras effector. J Biol Chem 1998;273:5439-42.
-
(1998)
J Biol Chem
, vol.273
, pp. 5439-5442
-
-
Vavvas, D.1
Li, X.2
Avruch, J.3
Zhang, X.F.4
-
34
-
-
85047696339
-
The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1
-
Ortiz-Vega S, Kholkhlatchev A, Nedwidek M, et al. The putative tumor suppressor RASSF1A homodimerizes and heterodimerizes with the Ras-GTP binding protein Nore1. Oncogene 2002;21:1381-90.
-
(2002)
Oncogene
, vol.21
, pp. 1381-1390
-
-
Ortiz-Vega, S.1
Kholkhlatchev, A.2
Nedwidek, M.3
-
35
-
-
0037133034
-
Identification of a novel Ras-regulated proapoptotic pathway
-
Khokhlatchev A, Rabizadeli S, Xavier R, et al. Identification of a novel Ras-regulated proapoptotic pathway. Curr Biol 2002;12:253-65.
-
(2002)
Curr Biol
, vol.12
, pp. 253-265
-
-
Khokhlatchev, A.1
Rabizadeli, S.2
Xavier, R.3
-
36
-
-
0036264815
-
The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation
-
Shivakumar L, Minna J, Sakamaki T, Pestell R, White MA. The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol Cell Biol 2002;22:4309-18.
-
(2002)
Mol Cell Biol
, vol.22
, pp. 4309-4318
-
-
Shivakumar, L.1
Minna, J.2
Sakamaki, T.3
Pestell, R.4
White, M.A.5
-
37
-
-
0344825077
-
Control of microtubule stability by the RASSF1A tumor suppressor
-
Liu L, Tommasi S, Lee DH, Dammann R, Pfeifer GP, Control of microtubule stability by the RASSF1A tumor suppressor. Oncogene 2003;22:8125-36.
-
(2003)
Oncogene
, vol.22
, pp. 8125-8136
-
-
Liu, L.1
Tommasi, S.2
Lee, D.H.3
Dammann, R.4
Pfeifer, G.P.5
-
38
-
-
1642602695
-
The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex
-
Song MS, Song SJ, Ayad NG, et al. The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex. Nat Cell Biol 2004;6:129-37.
-
(2004)
Nat Cell Biol
, vol.6
, pp. 129-137
-
-
Song, M.S.1
Song, S.J.2
Ayad, N.G.3
-
39
-
-
3042756223
-
Linking tumor suppression, DNA damage and the anaphase-promoting complex
-
Jackson PK. Linking tumor suppression, DNA damage and the anaphase-promoting complex. Trends Cell Biol 2004;14:331-4.
-
(2004)
Trends Cell Biol
, vol.14
, pp. 331-334
-
-
Jackson, P.K.1
-
41
-
-
18444379044
-
Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines
-
Harada K, Toyooka S, Maitra A, et al. Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines. Oncogene 2002;21:4345-9.
-
(2002)
Oncogene
, vol.21
, pp. 4345-4349
-
-
Harada, K.1
Toyooka, S.2
Maitra, A.3
-
42
-
-
0038545629
-
RASSF1A gene inactivation in non-small cell lung cancer and its clinical implication
-
Endoh H, Yatabe Y, Shimizu S, et al. RASSF1A gene inactivation in non-small cell lung cancer and its clinical implication. Int J Cancer 2003;106:45-51.
-
(2003)
Int J Cancer
, vol.106
, pp. 45-51
-
-
Endoh, H.1
Yatabe, Y.2
Shimizu, S.3
-
43
-
-
0035992419
-
Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinoma
-
Tomizawa Y, Kohno T, Kondo H, et al. Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinoma. Clin Cancer Res 2002:8:2362-8.
-
(2002)
Clin Cancer Res
, vol.8
, pp. 2362-2368
-
-
Tomizawa, Y.1
Kohno, T.2
Kondo, H.3
-
44
-
-
0042856354
-
RASSF1A promoter methylation and Kras2 mutations in non small cell lung cancer
-
Li J, Zhang Z, Dai Z, et al. RASSF1A promoter methylation and Kras2 mutations in non small cell lung cancer. Neoplasia 2003;5:362-6.
-
(2003)
Neoplasia
, vol.5
, pp. 362-366
-
-
Li, J.1
Zhang, Z.2
Dai, Z.3
-
45
-
-
2542432915
-
Haploinsufficiency for tumour suppressor genes: When you don't need to go all the way
-
Santarosa M, Ashworth A. Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way. Biochim Biophys Acta 2004;1654:105-22.
-
(2004)
Biochim Biophys Acta
, vol.1654
, pp. 105-122
-
-
Santarosa, M.1
Ashworth, A.2
-
46
-
-
0034643955
-
Accommodating haploinsufficient tumor suppressor genes in Knudson's model
-
Cook WD, McCaw BJ. Accommodating haploinsufficient tumor suppressor genes in Knudson's model. Oncogene 2000;19:3434-8.
-
(2000)
Oncogene
, vol.19
, pp. 3434-3438
-
-
Cook, W.D.1
McCaw, B.J.2
-
47
-
-
0033590626
-
Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma
-
Wistuba II, Behrens C, Milchgrub S, et al. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene 1999;18:643-50.
-
(1999)
Oncogene
, vol.18
, pp. 643-650
-
-
Wistuba, I.I.1
Behrens, C.2
Milchgrub, S.3
-
48
-
-
0035406393
-
High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss
-
Maitra A, Wistuba II, Washington C, et al. High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss. Am J Pathol 2001;159:119-30.
-
(2001)
Am J Pathol
, vol.159
, pp. 119-130
-
-
Maitra, A.1
Wistuba, I.I.2
Washington, C.3
-
49
-
-
0037427083
-
Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients
-
Honorio S, Agathanggelou A, Schuermann M, et al. Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients. Oncogene 2003;22:147-50.
-
(2003)
Oncogene
, vol.22
, pp. 147-150
-
-
Honorio, S.1
Agathanggelou, A.2
Schuermann, M.3
-
50
-
-
1642272931
-
Early occurrence of RASSF1A hypermethylation and its mutual exclusion with BRAF mutation in thyroid tumorigenesis
-
Xing M, Cohen Y, Mambo E, et al. Early occurrence of RASSF1A hypermethylation and its mutual exclusion with BRAF mutation in thyroid tumorigenesis. Cancer Res 2004;64:1664-8.
-
(2004)
Cancer Res
, vol.64
, pp. 1664-1668
-
-
Xing, M.1
Cohen, Y.2
Mambo, E.3
-
51
-
-
0037434724
-
NORE1A, a homologue of RASSF1A tumour suppressor gene is inactivated in human cancers
-
Hesson L, Dallol A, Minna JD, Maher ER, Latif F. NORE1A, a homologue of RASSF1A tumour suppressor gene is inactivated in human cancers. Oncogene 2003;22:947-54.
-
(2003)
Oncogene
, vol.22
, pp. 947-954
-
-
Hesson, L.1
Dallol, A.2
Minna, J.D.3
Maher, E.R.4
Latif, F.5
-
52
-
-
10744226004
-
The t(1;3) breakpoint-spanning genes LSAMP and NORE1 are involved in clear cell renal cell carcinomas
-
Chen J, Lui WO, Vos MD, et al. The t(1;3) breakpoint-spanning genes LSAMP and NORE1 are involved in clear cell renal cell carcinomas. Cancer Cell 2003;4:405-13.
-
(2003)
Cancer Cell
, vol.4
, pp. 405-413
-
-
Chen, J.1
Lui, W.O.2
Vos, M.D.3
-
53
-
-
0034680870
-
Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis
-
Vos MD, Ellis CA, Bell A, Birrer MJ, Clark GJ. Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis. J Biol Chem 2000;275:35669-72.
-
(2000)
J Biol Chem
, vol.275
, pp. 35669-35672
-
-
Vos, M.D.1
Ellis, C.A.2
Bell, A.3
Birrer, M.J.4
Clark, G.J.5
-
54
-
-
17944369909
-
Wildtype Kras2 can inhibit lung carcinogenesis in mice
-
Zhang Z, Wang Y, Vikis HG, et al. Wildtype Kras2 can inhibit lung carcinogenesis in mice. Nat Genet 2001;29:25-33.
-
(2001)
Nat Genet
, vol.29
, pp. 25-33
-
-
Zhang, Z.1
Wang, Y.2
Vikis, H.G.3
|